Biagio Ricciuti (B Ricciuti)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 50

Top Topics

Body Mass Index

Tyrosine Kinase

Dna Damage Response

Epidermal Growth Factor Receptor

Top Venues

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Stefano Scalera, Biagio Ricciuti, Daniele Marinelli, Marco Mazzotta, Laura Cipriani, Giulia Bon, Giulia Schiavoni, Irene Terrenato, Alessandro Di Federico, Joao M Victor Alessi, Maurizio Fanciulli, Ludovica Ciuffreda, Francesca De Nicola, Frauke Goeman, Giulio Caravagna, Daniele Santini, Ruggero De Maria, Federico Cappuzzo, Gennaro Ciliberto, Mariam Jamal-Hanjani, Mark M Awad, Nicholas McGranahan, Marcello Maugeri-Saccà
Transcriptional phenocopies of deleterious KEAP1 mutations correlate with survival outcomes in lung cancer treated with immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors. Cancer discovery (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Csaba Kerepesi, Hassan Mohammed Abushukair, Biagio Ricciuti, Amin H Nassar, Elio Adib, Joao M Victor Alessi, Federica Pecci, Mehrdad Rakaee, Muhammad Zaki Hidayatullah Fadlullah, Anna-Mária Tőkés, Scott J Rodig, Mark M Awad, Aik Choon Tan, Tibor Bakacs, Abdul Rafeh Naqash
Association of Baseline Tumor-Specific Neoantigens and CD8 + T-Cell Infiltration With Immune-Related Adverse Events Secondary to Immune Checkpoint Inhibitors. JCO precision oncology 8 (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Abdul Rafeh Naqash, Charalampos S Floudas, Etan Aber, Asaf Maoz, Amin H Nassar, Elio Adib, Khalil Choucair, Joanne Xiu, Yasmine Baca, Biagio Ricciuti, Joao M Victor Alessi, Mark M Awad, Chul Kim, Julia Judd, Luis E Raez, Gilberto de Lima Lopes, Jorge J Nieva, Hossein Borghaei, Naoko Takebe, Patrick C Ma, Balazs Halmos, David J Kwiatkowski, Stephen V Liu, Hirva Mamdani
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11 -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 8 (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Federica Pecci, Seshiru Nakazawa, Biagio Ricciuti, Guilherme Harada, Jessica K Lee, Joao M Victor Alessi, Adriana P Barrichello, Victor R Vaz, Giuseppe Lamberti, Alessandro Di Federico, Malini M Gandhi, Dimitrios Gazgalis, William W Feng, Jie Jiang, Simon Baldacci, Marie-Anaïs Locquet, Felix H Gottlieb, Monica F Chen, Elinton Lee, Danielle Haradon, Anna Smokovich, Emma Voligny, Tom Nguyen, Vikas K Goel, Zachary Zimmerman, Sumandeep Atwal, Xinan Wang, Magda Bahcall, Rebecca S Heist, Sumaiya Iqbal, Nishant Gandhi, Andrew Elliott, Ari M VanderWalde, Patrick C Ma, Balazs Halmos, Stephen V Liu, Jianwei Che, Alexa B Schrock, Alexander E Drilon, Pasi A Janne, Mark M Awad
Activating Point Mutations in the MET Kinase Domain Represent a Unique Molecular Subset of Lung Cancer and Other Malignancies Targetable with MET Inhibitors. Cancer discovery 14 (8) (2024)
Biagio Ricciuti, Giuseppe Lamberti, Sreekar R Puchala, Navin R Mahadevan, Jia-Ren Lin, Joao M Victor Alessi, Alexander Chowdhury, Yvonne Y Li, Xinan Wang, Liam Spurr, Federica Pecci, Alessandro Di Federico, Deepti Venkatraman, Adriana P Barrichello, Malini M Gandhi, Victor R Vaz, Andy J Pangilinan, Danielle Haradon, Elinton Lee, Hersh V Gupta, Kathleen L Pfaff, Emma L Welsh, Mizuki Nishino, Andrew D Cherniack, Bruce E Johnson, Jason L Weirather, Ian D Dryg, Scott J Rodig, Lynette M Sholl, Peter Karl Sorger, Sandro Santagata, Renato Umeton, Mark M Awad
Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Malini M Gandhi, Biagio Ricciuti, Guilherme Harada, Matteo Repetto, Melissa S Gildenberg, Ankit Singh, Yvonne Y Li, Andréanne Gagné, Xinan Wang, Ayal A Aizer, Kelly N Fitzgerald, Mizuki Nishino, Joao M Victor Alessi, Federica Pecci, Alessandro Di Federico, Adam S Fisch, Alexander E Drilon, Valentina Nardi, Lynette M Sholl, Mark M Awad, Julia Rotow
Amplification of Wild-Type RET Represents a Novel Molecular Subtype of Several Cancer Types With Clinical Response to Selpercatinib. JCO precision oncology 7 (2023)
Joao M Victor Alessi, Adam Price, Allison L Richards, Biagio Ricciuti, Xinan Wang, Arielle Elkrief, Federica Pecci, Alessandro Di Federico, Malini M Gandhi, Emily S Lebow, Patricia Mae G Santos, Maria Thor, Andreas Rimner, Adam J Schoenfeld, Jamie E Chaft, Bruce E Johnson, Daniel R Gomez, Mark M Awad, Narek Shaverdian
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer. Journal for immunotherapy of cancer 11 (11) (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Giuseppe Lamberti, Ayal A Aizer, Biagio Ricciuti, Joao M Victor Alessi, Federica Pecci, Shu-Chi Tseng, Lynette M Sholl, Mizuki Nishino, Mark M Awad
Incidence of Brain Metastases and Preliminary Evidence of Intracranial Activity With Sotorasib in Patients With KRAS G12C -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 7 (2023)
Rohit Thummalapalli, Biagio Ricciuti, Chaitanya Bandlamudi, Daniel M Muldoon, Hira A Rizvi, Arielle Elkrief, Jia Luo, Joao M Victor Alessi, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Lingzhi Hong, Jianjun Zhang, John Victor Heymach, Don L Gibbons, Andrew J Plodkowski, Vignesh Ravichandran, Mark T A Donoghue, Chad M Vanderbilt, Marc Ladanyi, Charles M Rudin, Mark G Kris, Gregory J Riely, Jamie E Chaft, Matthew D Hellmann, Natalie I Vokes, Mark M Awad, Adam J Schoenfeld
Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Arielle Elkrief, Joao M Victor Alessi, Biagio Ricciuti, Samantha Brown, Hira Rizvi, Isabel R Preeshagul, Xinan Wang, Federica Pecci, Alessandro Di Federico, Giuseppe Lamberti, Jacklynn V Egger, Jamie E Chaft, Charles M Rudin, Gregory J Riely, Mark G Kris, Marc Ladanyi, Yuan Chen, Matthew D Hellmann, Ronglai Shen, Mark M Awad, Adam J Schoenfeld
Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: a cohort study. Journal for immunotherapy of cancer 11 (7) (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Juan Bautista Blaquier, Sandra Ortiz-Cuaran, Biagio Ricciuti, Laura Mezquita, Andrés Felipe Cardona, Gonzalo Recondo
Tackling osimertinib resistance in EGFR mutant non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alessandro Di Federico, Ilaria Ricciotti, Valentina Favorito, Sandra Vietti Michelina, Pietro Scaparone, Giulio Metro, Andrea De Giglio, Federica Pecci, Giuseppe Lamberti, Chiara Ambrogio, Biagio Ricciuti
Resistance to KRAS G12C Inhibition in Non-small Cell Lung Cancer. Current oncology reports (2023)
Giuseppe Lamberti, Ayal A Aizer, Biagio Ricciuti, Joao M Victor Alessi, Federica Pecci, Shu-Chi Tseng, Lynette M Sholl, Mizuki Nishino, Mark M Awad
Incidence of Brain Metastases and Preliminary Evidence of Intracranial Activity With Sotorasib in Patients With KRAS G12C -Mutant Non-Small-Cell Lung Cancer. JCO precision oncology 7 (2023)
Biagio Ricciuti, Arielle Elkrief, Joao M Victor Alessi, Xinan Wang, Yvonne Y Li, Hersh V Gupta, Daniel M Muldoon, Arrien A Bertram, Federica Pecci, Giuseppe Lamberti, Alessandro Di Federico, Adriana P Barrichello, Victor R Vaz, Malini M Gandhi, Elinton Lee, Geoffrey I Shapiro, Hyesun Park, Mizuki Nishino, James R Lindsay, Kristen D Felt, Bijaya Sharma, Andrew D Cherniak, Scott J Rodig, Daniel R Gomez, Narek Shaverdian, Mehrdad Rakaee, Chaitanya Bandlamudi, Marc Ladanyi, Pasi A Janne, Adam J Schoenfeld, Lynette M Sholl, Mark M Awad, Michael L Cheng
Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Marcelo Vailati Negrão, Haniel A Araujo, Giuseppe Lamberti, Alissa J Cooper, Neal S Akhave, Teng Zhou, Lukas Delasos, J Kevin Hicks, Mihaela Aldea, Gabriele Minuti, Jacobi Hines, Jacqueline V Aredo, Michael J Dennis, Turja Chakrabarti, Susan C Scott, Paolo Bironzo, Matthias Scheffler, Petros Christopoulos, Albrecht Stenzinger, Jonathan W Riess, So Yeon Kim, Sarah B Goldberg, Mingjia Li, Qi Wang, Yun Qing, Ying Ni, Minh Truong Do, Richard Lee, Biagio Ricciuti, Joao M Victor Alessi, Jing Wang, Blerina Resuli, Lorenza Landi, Shu-Chi Tseng, Mizuki Nishino, Subba R Digumarthy, Waree Rinsurongkawong, Vadeerat Rinsurongkawong, Ara A Vaporciyan, George R Blumenschein, Jianjun Zhang, Dwight H Owen, Collin M Blakely, Giannis S Mountzios, Catherine A Shu, Christine M Bestvina, Marina-Chiara Garassino, Kristen A Marrone, Jhanelle E Gray, Sandip Pravin Patel, Amy L Cummings, Heather A Wakelee, Juergen Wolf, Giorgio Vittorio Scagliotti, Federico Cappuzzo, Fabrice Barlesi, Pradnya D Patil, Leylah Drusbosky, Don L Gibbons, Funda Meric-Bernstam, Jiun-Kae Jack Lee, John Victor Heymach, David S Hong, Rebecca S Heist, Mark M Awad, Ferdinandos Skoulidis
Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC. Cancer discovery (2023)
Robert B Scharpf, Archana Balan, Biagio Ricciuti, Jacob Fiksel, Christopher M Cherry, Chenguang Wang, Michele L LeNoue-Newton, Hira A Rizvi, James Robert White, Alexander S Baras, Jordan Anaya, Blair V Landon, Marta Majcherska-Agrawal, Paola Ghanem, Jocelyn Lee, Leon Raskin, Andrew S Park, Huakang Tu, Hilary K Hsu, Kathryn C Arbour, Mark M Awad, Gregory J Riely, Christine M Lovly, Valsamo Anagnostou
Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers. Cancer research 82 (21) (2022)
Biagio Ricciuti, Jieun Son, Jeffrey J Okoro, Alessia Mira, Enrico Patrucco, Yoonji Eum, Xinan Wang, Raymond Paranal, Haiyun Wang, Mika Lin, Heidi M Haikala, Jiaqi Li, Yue Xu, Joao M Victor Alessi, Chhayheng Chhoeu, Amanda J Redig, Jens Köhler, Kshiti H Dholakia, Yunhan Chen, Elodie Richard, Marie-Julie Nokin, David Santamaria, Prafulla C Gokhale, Mark M Awad, Pasi A Janne, Chiara Ambrogio
Comparative Analysis and Isoform-Specific Therapeutic Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (8) (2022)
Michael L Cheng, Marina S D Milan, Rubii M Tamen, Arrien A Bertram, Kesi S Michael, Biagio Ricciuti, Kenneth L Kehl, Mark M Awad, Lynette M Sholl, Cloud P Paweletz, Pasi A Jänne
Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLC. JCO precision oncology 5 (2022)
Alessio Cortellini, Biagio Ricciuti, Victor R Vaz, Davide Soldato, Joao M Victor Alessi, Filippo G Dall'Olio, Giuseppe L Banna, Sethupathi Muthuramalingam, Samuel Chan, Margarita Majem Tarruella, Aida Piedra, Giuseppe Lamberti, Elisa Andrini, Alfredo Addeo, Alex Friedlaender, Francesco Facchinetti, Teresa Gorría, Laura Mezquita, Delphine Hoton, Lacroix Valerie, Frank Aboubakar Nana, James Artingstall, Charles Comins, Massimo Di Maio, Andrea Caglio, Judith Cave, Hayley McKenzie, Thomas Newsom-Davis, Joanne S Evans, Marcello Tiseo, Antonio D'Alessio, Claudia A M Fulgenzi, Benjamin Besse, Mark M Awad, David James Pinato
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations. Journal for immunotherapy of cancer 10 (2) (2022)
Xinan Wang, Biagio Ricciuti, Tom Nguyen, Xihao Li, Michael S Rabin, Mark M Awad, Xihong Lin, Bruce E Johnson, David Chistopher Christiani
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung Cancer. Cancer research 81 (9) (2021)
Biagio Ricciuti, Greg Jones, Mariano Severgnini, Joao M Victor Alessi, Gonzalo Recondo, Marissa Lawrence, Tim Forshew, Christine Lydon, Mizuki Nishino, Michael Cheng, Mark Awad
Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC). Journal for immunotherapy of cancer 9 (3) (2021)
Joao M Victor Alessi, Biagio Ricciuti, Stephanie L Alden, Arrien A Bertram, Jessica J Lin, Mustafa Sakhi, Mizuki Nishino, Victor R Vaz, James Lindsay, Madison M Turner, Kathleen Pfaff, Bijaya Sharma, Kristen D Felt, Scott J Rodig, Justin F Gainor, Mark M Awad
Low peripheral blood derived neutrophil-to-lymphocyte ratio (dNLR) is associated with increased tumor T-cell infiltration and favorable outcomes to first-line pembrolizumab in non-small cell lung cancer. Journal for immunotherapy of cancer 9 (11) (2021)
Mizuki Nishino, Fangxin Hong, Biagio Ricciuti, Hiroto Hatabu, Mark M Awad
Tumor Response Dynamics During First-Line Pembrolizumab Therapy in Patients With Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 5 (2021)
Biagio Ricciuti, Gonzalo Recondo, Liam F Spurr, Yvonne Y Li, Giuseppe Lamberti, Deepti Venkatraman, Renato Umeton, Andrew D Cherniak, Mizuki Nishino, Lynette M Sholl, Geoffrey I Shapiro, Mark M Awad, Michael L Cheng
Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L)1 Immune Checkpoint Inhibition in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (15) (2020)
Gonzalo Recondo, Magda Bahcall, Liam F Spurr, Jianwei Che, Biagio Ricciuti, Giulia C Leonardi, Ying-Chun Lo, Yvonne Y Li, Giuseppe Lamberti, Tom Nguyen, Marina S D Milan, Deepti Venkatraman, Renato Umeton, Cloud P Paweletz, Adem Albrayak, Andrew D Cherniack, Kristin S Price, Stephen R Fairclough, Mizuki Nishino, Lynette M Sholl, Geoffrey R Oxnard, Pasi A Jänne, Mark M Awad
Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14-Mutant NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Giuseppe Lamberti, Elisa Andrini, Monia Sisi, Alessandro Di Federico, Biagio Ricciuti
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: rationale and clinical implication. Future oncology (London, England) 16 (23) (2020)
Biagio Ricciuti, Sara Baglivo, Andrea De Giglio, Rita Chiari
Afatinib in the first-line treatment of patients with non-small cell lung cancer: clinical evidence and experience. Therapeutic advances in respiratory disease 12 (2019)
Biagio Ricciuti, M Brambilla, A Cortellini, A De Giglio, C Ficorella, A Sidoni, G Bellezza, L Crinò, V Ludovini, S Baglivo, G Metro, R Chiari
Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (5) (2019)
Biagio Ricciuti, Giulia C Leonardi, Marta Brambilla
Emerging Biomarkers in the Era of Personalized Cancer Medicine. Disease markers 2019 (2019)
Biagio Ricciuti, Carlo Genova, Andrea De Giglio, Maria Bassanelli, Maria Giovanna Dal Bello, Giulio Metro, Marta Brambilla, Sara Baglivo, Francesco Grossi, Rita Chiari
Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis. Journal of cancer research and clinical oncology 145 (2) (2018)
Biagio Ricciuti, Andrea De Giglio, Carmen Mecca, Cataldo Arcuri, Sabrina Marini, Giulio Metro, Sara Baglivo, Angelo Sidoni, Guido Bellezza, Lucio Crinò, Rita Chiari
Precision medicine against ALK-positive non-small cell lung cancer: beyond crizotinib. Medical oncology (Northwood, London, England) 35 (5) (2018)
Biagio Ricciuti, Jennifer Foglietta, Rita Chiari, Amirhossein Sahebkar, Maciej Banach, Vanessa Bianconi, Matteo Pirro
Emerging enzymatic targets controlling angiogenesis in cancer: preclinical evidence and potential clinical applications. Medical oncology (Northwood, London, England) 35 (1) (2017)